NCT02784990View on ClinicalTrials.gov

Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions

CompletedOBSERVATIONAL

Enrollment

770

Participants

Timeline

Start Date

June 3, 2016

Primary Completion Date

November 3, 2020

Study Completion Date

November 3, 2020

Conditions

Pancreatic Fistula

Interventions

BIOLOGICAL

Lipase, amylase and CRP (C-reactive protein) dosages

Trial Locations (10)

13009

APHM - Institut Paoli-Calmettes, Marseille

21079

CHU Dijon Bourgogne, Dijon

25030

CHU Jean Minjoz, Besançon

38700

CHU Grenoble Alpes, La Tronche

51100

CHU de REIMS - Hôpital Robert Debré, Reims

54511

CHU de NANCY, Vandœuvre-lès-Nancy

59037

Hopital Claude Huriez, Lille

67098

Hôpital Hautepierre, Strasbourg

69317

HCL - Hôpital universitaire de la Croix Rousse, Lyon

71321

CHU William MOREY, Chalon-sur-Saône

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02784990 - Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions | Biotech Hunter | Biotech Hunter